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Characterizing Patch Test Findings in African American ACD Patients 
Vaibhav Garg, Bruce Brod, Anthony Gaspari* 
Introduction: Allergic Contact Dermatitis (ACD) in African Americans has not been well 
studied, and there is little information related to differences in patterns of ACD between African 
Americans and Caucasians. This paper aims to investigate relative differences in patterns of 
sensitization in African American ACD patients. 
Methods: This study is a retrospective descriptive study. Data of ACD patients patch tested from 
2009-2019 by Dr. Gaspari and Dr. Brod at TJUH and HUP/UPHS were reviewed. Patch test 
findings for African American and Caucasian patients were compared. Outcomes such as 
positive allergens, strength, clinical relevance, patient occupation, and personal product use were 
measured. The exclusion criteria included patients that had undergone patch testing with 
inconclusive results (technical problem with patch tests, or the patient did not return for all patch 
test readings).  
Results: The total sample size is approximately 450-500 patients, depending on further 
exclusion. Data analysis of ACD in African American patients (n = 47) is complete, therefore 
results below pertain only to this subgroup. Gold, nickel, MI/MCI, disperse dyes, PPD, textile 
dyes, and fragrance mixes were the most common positive allergens. 21 patients had definite 
clinically relevant reactions, while 6 were probable. The rest were questionable or no relevance. 
More conclusive data analyses will be reported once the data is complete.  
Discussion: Different patterns of allergy may occur due to differing patterns of exposure to 
personal care products (cultural), genetic susceptibility, and/or healthcare disparities. Addressing 
this may be useful for preventative purposes and for offering safer alternatives to common 
allergens.  
